Key result
Patient-specific CPVT-hiPSC-derived cardiomyocytes exhibit ~6x more delayed afterdepolarizations than healthy controls.
Authors
Loading...
Experimental stem cell study demonstrates arrhythmogenic calcium handling in patient-derived cardiomyocytes, highlighting therapeutic targets for catecholaminergic polymorphic ventricular tachycardia.
Absolute Event Rate: 69% vs 11%
Itzhaki et al. (2012) studied Catecholaminergic polymorphic ventricular tachycardia (CPVT) (n=1). Patient-specific CPVT-hiPSCs-derived cardiomyocytes vs. Healthy control hiPSCs-derived cardiomyocytes was evaluated on Development of delayed afterdepolarizations. Patient-specific CPVT-hiPSCs-derived cardiomyocytes exhibited delayed afterdepolarizations in 69% of cells compared with 11% in healthy control cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: